AnkurVarmaMD
Oncology • Little Rock, ARHematologic Oncology
Associate Professor Department of Internal Medicine, Division of Hematology, Oncology. Stem Cell Transplantation and Cellular Therapy University of Arkansas for Medical Sciences
Dr. Varma is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4301 W Markham St
Little Rock, AR 72205Phone+1 501-686-8530
Summary
- He is an ABIM Board-certified hematologist and oncologist. His areas of expertise are Bone Marrow transplantation with a special focus on alternate donor transplants, Chimeric antigen receptor (CAR) T-cell therapy, and Hematological malignancies.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Blood & Bone Marrow Transplant, 2018 - 2019
Baylor College of MedicineFellowship, Hematology and Medical Oncology, 2015 - 2018
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2012 - 2015
RG Kar Medical College CalcuttaClass of 2009
Certifications & Licensure
AR State Medical License 2023 - 2026
IL State Medical License 2019 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 35 citationsIs there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantationStefan O. Ciurea, Piyanuch Kongtim, Ankur Varma, Gabriela Rondon, Julianne Chen
Blood. 2020-02-06 - 33 citationsEffect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2-positive metastatic breast cancerRashmi Krishna Murthy, Ankur Varma, Priyankana Mishra, Kenneth R. Hess, Elliana Young
Cancer. 2014-07-01 - 92 citationsValidation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain MetastasesIshwaria Mohan Subbiah, Xiudong Lei, Jeffrey S. Weinberg, Erik P. Sulman, Mariana Chavez-MacGregor
Journal of Clinical Oncology. 2015-05-18
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
